Radovan Keul

421 total citations
8 papers, 358 citations indexed

About

Radovan Keul is a scholar working on Molecular Biology, Pharmacology and Oncology. According to data from OpenAlex, Radovan Keul has authored 8 papers receiving a total of 358 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 2 papers in Pharmacology and 2 papers in Oncology. Recurrent topics in Radovan Keul's work include Inflammatory mediators and NSAID effects (2 papers), Monoclonal and Polyclonal Antibodies Research (2 papers) and Cytokine Signaling Pathways and Interactions (2 papers). Radovan Keul is often cited by papers focused on Inflammatory mediators and NSAID effects (2 papers), Monoclonal and Polyclonal Antibodies Research (2 papers) and Cytokine Signaling Pathways and Interactions (2 papers). Radovan Keul collaborates with scholars based in Germany, Switzerland and Netherlands. Radovan Keul's co-authors include John Wijdenes, Gerhard Müller‐Newen, Ulrike Hemmann, Andrea Küster, Ursula Horsten, Peter C. Heinrich, Lutz Graeve, Patricia Woo, Michael Roth and Klaus Müller and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Journal of Immunology and European Journal of Biochemistry.

In The Last Decade

Radovan Keul

8 papers receiving 346 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Radovan Keul Germany 7 157 149 99 43 37 8 358
J R Megill United States 5 202 1.3× 140 0.9× 66 0.7× 28 0.7× 28 0.8× 6 412
F D'Alessandro Italy 8 165 1.1× 125 0.8× 101 1.0× 19 0.4× 91 2.5× 16 418
Liene Ņikitina-Zaķe Latvia 13 106 0.7× 71 0.5× 159 1.6× 15 0.3× 38 1.0× 30 500
Venkateshwari Ananthapur India 15 134 0.9× 92 0.6× 154 1.6× 19 0.4× 17 0.5× 73 547
Sajjad Rafiq United Kingdom 12 134 0.9× 82 0.6× 157 1.6× 15 0.3× 40 1.1× 16 511
Erin Naismith Austria 9 165 1.1× 68 0.5× 69 0.7× 24 0.6× 41 1.1× 11 336
Joanna Więckiewicz Poland 10 413 2.6× 100 0.7× 90 0.9× 37 0.9× 19 0.5× 13 663
Larissa Lamertz Germany 6 167 1.1× 146 1.0× 97 1.0× 16 0.4× 21 0.6× 7 396
Michał Pyźlak Poland 15 157 1.0× 49 0.3× 103 1.0× 37 0.9× 28 0.8× 52 528
Keiji Sakai Japan 16 131 0.8× 27 0.2× 140 1.4× 27 0.6× 26 0.7× 24 486

Countries citing papers authored by Radovan Keul

Since Specialization
Citations

This map shows the geographic impact of Radovan Keul's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Radovan Keul with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Radovan Keul more than expected).

Fields of papers citing papers by Radovan Keul

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Radovan Keul. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Radovan Keul. The network helps show where Radovan Keul may publish in the future.

Co-authorship network of co-authors of Radovan Keul

This figure shows the co-authorship network connecting the top 25 collaborators of Radovan Keul. A scholar is included among the top collaborators of Radovan Keul based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Radovan Keul. Radovan Keul is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Müller‐Newen, Gerhard, Andrea Küster, Ulrike Hemmann, et al.. (1998). Soluble IL-6 Receptor Potentiates the Antagonistic Activity of Soluble gp130 on IL-6 Responses. The Journal of Immunology. 161(11). 6347–6355. 141 indexed citations
2.
Keul, Radovan, et al.. (1998). A POSSIBLE ROLE FOR SOLUBLE IL-6 RECEPTOR IN THE PATHOGENESIS OF SYSTEMIC ONSET JUVENILE CHRONIC ARTHRITIS. Cytokine. 10(9). 729–734. 74 indexed citations
3.
Keul, Radovan, S Matern, M. Hart, et al.. (1996). Purification and characterization of the soluble interleukin-6 receptor from human plasma and identification of an isoform generated through alternative splicing. RWTH Publications (RWTH Aachen). 8 indexed citations
4.
Müller‐Newen, Gerhard, Radovan Keul, Ulrike Hemmann, et al.. (1996). Purification and Characterization of the Soluble Interleukin‐6 Receptor from Human Plasma and Identification of An Isoform Generated through Alternative Splicing. European Journal of Biochemistry. 236(3). 837–842. 57 indexed citations
5.
Keul, Radovan, Michael Roth, Eleni Papakonstantinou, et al.. (1996). Induction of interleukin 6 and interleukin 8 expression by Broncho-Vaxom (OM-85 BV) via C-Fos/serum responsive element.. Thorax. 51(2). 150–154. 17 indexed citations
6.
Roth, Michael, Radovan Keul, André P. Perruchoud, & L H Block. (1993). Manidipine affects rPDGF-BB-induced gene transcription of low-density lipoprotein receptors and 3-hydroxy-3-methylglutaryl coenzyme A reductase in human mesangial cells. American Heart Journal. 125(2). 598–603. 6 indexed citations
7.
Block, L H, Radovan Keul, Maryse Crabos, Rolf Ziesche, & Michael Roth. (1993). Transcriptional activation of low density lipoprotein receptor gene by angiotensin-converting enzyme inhibitors and Ca(2+)-channel blockers involves protein kinase C isoforms.. Proceedings of the National Academy of Sciences. 90(9). 4097–4101. 16 indexed citations
8.
Roth, Michael, Radovan Keul, Lyman R. Emmons, Walter H. Hörl, & L H Block. (1992). Manidipine regulates the transcription of cytokine genes.. Proceedings of the National Academy of Sciences. 89(9). 4071–4075. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026